個別化医療におけるナノマテリアルの世界市場は、2023 年の 3,467 億ドルから 2028 年末までに 5,920 億ドルに増加すると予想され、2023 年から 2028 年までの予測期間中のCAGRは11.3% となる見込みです。
目次
Chapter- 1: Introduction
Overview of Nanotheranostics
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
Chapter- 2: Summary and Highlights
Market Outlook
Market Insights
Chapter- 3: Market Overview
Market Overview
Theranostics and Personalized Medicines Overview
Nanoparticles
Nanotechnology Overview
Nanotheranostic Drug Delivery
Future Perspectives
Chapter- 4: Nanodevices and Nanomaterials in Diagnostics
Overview
Molecular Recognition in Diagnosis
Nanopatterned Devices
Particles
Carbon Nanotubes
Fullerene C60
Cancer
Magnetic Nanoparticles
Quantum Dots
Aptamer-Conjugated Nanoparticles
Nanoparticle-Based Bio-Bar Codes
Multiplex Dendrimers
Surface Enhanced Raman Spectroscopy
Diagnostic and Medical Device Industry
Multifunctional Nanoparticles
Conclusion and Future Trends
Chapter- 5: Treatments Based on Nanomaterial for Infections Associated with Medical Devices
Infections Associated with Medical Devices and Their Treatments
Common Methods for Preventing and Treating Medical Device-Associated Infections
Nanomaterials in Personalized Medicine
Chapter- 6: Biomedical Nanoparticle Products
Introduction
Nanoparticle Drug Delivery Systems and Products
Chapter- 7: Therapeutic and Diagnostic Companion Kits
Introduction
Chapter- 8: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Chapter- 9: Regulatory Landscape
Overview
Regulatory Issues in Nanotechnology
Chapter- 10: Impact of COVID-19 on the Market
Overview
Components and Methods in the Design of a Vaccine
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusions Regarding Use of Nanotechnology to Combat COVID-19
Chapter- 11: Market Breakdown by Product Type
Market Overview
Chapter- 12: Market Breakdown by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 13: ESG Development
Introduction to ESG
Chapter- 14: Emerging Technologies
Overview
Current Market Trends
Emerging Technologies
Chapter- 15: Patents and Pipeline Analysis
Overview
Patent Analysis
Pipeline Analysis
Chapter- 16: M&A Outlook
M&A Analysis
Chapter- 17: Competitive Landscape
Overview
Distribution of Nanobiotechnology and Nanomedicine Companies
Company Share Analysis
Chapter- 18: Company Profiles
BRISTOL-MYERS SQUIBB
CAMURUS AB
CYTIMMUNE SCIENCES
EISAI
GILEAD SCIENCES INC.
IPSEN PHARMA
Chapter- 19: Appendix: Acronyms
Table 74 : Acronyms Used in This Report
